The Vox Markets Podcast

Vox Markets Podcast

Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "The Vox Markets Podcast" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

The Vox Markets Podcast

Episodes (500)

Yesterday Poolbeg’s Big Biotech Moment? First Patient Dosed Ahead of Key POLB 001 Data
Yesterday European Green Transition: Potential £126m Repowering Revenue Opportunity
Friday 2 P's on a Pod: What Happens Next for UK Small Caps?

The Vox Markets Podcast

Jul 13, 2026
8¼ minutes
0

Watch on YouTube Poolbeg Pharma has dosed the first patient in its POLB 001 TOPICAL clinical trial, marking the start of a key execution phase for its CRS prevention programme. With UCLH activated, further sites expected, interim data targeted for summer 2026 and partnering discussions ongoing, investors will be watching whether clinical progress can validate the programme’s claimed commercial potential.

The Vox Markets Podcast

Poolbeg’s Big Biotech Moment? First Patient Dosed Ahead of Key POLB 001 Data

Vox Markets Podcast

00:00 -08:20